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Antibiotic resistance is a worldwide health 
problem in many fields, such as human and 
veterinary medicine, livestock holdings, agri-
culture and environment (Marshall et al., 2011). 
In recent years, the spread of Enterobacteriace-
ae resistant to 3rd and 4th generation cephalo-
sporins in farm animals was highlighted as an 
emerging problem. Such resistance has been 
demonstrated to be related to extended-spec-
trum β-lactamase (ESBL) production. (Li et al., 
2007). ESBL are plasmid-encoded enzymes, 
capable of inactivating a large number of 
β-lactam antibiotics, including extended-spec-
trum and very-broad-spectrum cephalosporins 
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The aim of this study was to assess the production of extended spectrum beta-lactamases (ESBL) in 56 strains of 
Enterobacteriaceae, obtained from 100 rectal swabs of farm animals, and to evaluate the horizontal transfer ca-
pacity of the genetic determinants of resistance. The ESBL-positive strains were confirmed by phenotypic testing, 
confirmed by PCR and DNA sequence analysis. The localization of beta-lactamase genes was established by conju-
gation experiments. Of the 56 analyzed strains, 20 (36%) resulted positive for ESBL production by the double-disk 
synergy test, and belonged to Escherichia coli 15 (75%) and Klebsiella ozaenae 5 (25%) species. Molecular analysis 
showed that all ESBL-producing isolates possessed genes encoding for TEM-type enzymes and/or CTX-M. The 
conjugation assays yielded positive results, thus denoting a plasmidic localization of the genes. This study high-
lights the high percentage of ESBL-positive Enterobacteriaceae and the mobility of the responsible genes. Gene mo-
bility implies highly negative consequences in terms of drug therapy because of the spread of antibiotic resistance.
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and monobactams. The ESBL are also com-
monly inhibited by β-lactamase inhibitors, such 
as clavulanic acid, sulbactam, and tazobactam. 
Furthermore, resistance to broad-spectrum 
cephalosporins can be due to overexpression of 
chromosomal or plasmid-mediated AmpC en-
zymes, encoded by genes such as blaCMY-2. Such 
enzymes also confer resistance to cephamycins 
and cannot be inhibited by the β-lactamase in-
hibitors. In humans, Enterobacteriaceae able 
to produce ESBLs and AmpC broad-spectrum 
β-lactamases have been studied for more than 
two decades (Bradford, 2001, Paterson et al., 
2005). ESBL genes are usually transported by 
plasmids, facilitating so their spread among 
Gram-negative bacilli.
The most frequently reported ESBL subtypes 
in both Salmonella and Escherichia coli from 
food-producing animals and foods within the 
European Union (EU) are CTX-M-1, CTX-M-14, 
TEM-52 and SHV-12 (Chiaretto et al., 2008). 
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A wide range of additional CTX-M subtypes 
(CTX-M-1, -2, -3, -8, -9, -14, -15, -17/18, -20, -32, 
-53) (EFSA, 2011), TEM (TEM-20, -52, -106, 
-126) and SHV variants (SHV-2, -5, -12) (Chi-
aretto et al., 2008, Endimiani et al., 2012) have 
been detected in both food-producing animals 
and in food, in several European countries. In 
Italy, the prevalence of ESBL-producing Sal-
monella is 0.5-0.6%, but in this study, isolates 
of E. coli ESBL-carrying were found in all the 
five poultry farms tested (Bortolaia et al., 2010). 
The massive and indiscriminate use of different 
classes of antibiotics in the veterinary context 
has contributed to the selection and spread of 
multidrug-resistant Enterobacteriaceae. Live-
stock animals are considered important res-
ervoirs of antibiotic-resistant Gram-negative 
bacteria and their role on human health has 
drawn considerable global attention (Aiello et 
al., 2003, Seiffert et al., 2013). For this purpose, 
100 rectal swabs of healthy food-producing an-
imals were analyzed to detect and characterize 
the production of ESBL by Enterobacteriaceae 
and the ability of horizontal transfer of the ge-
netic determinants of resistance.
From February to July 2013, 100 rectal swab 
samples were collected from healthy food-pro-
ducing animals (50 breeding pigs and 50 dairy 
cattle) from 4 farms in Modena (Italy). Rec-
tal samples were seeded on MacConkey agar 
(bioMérieux, Florence, Italy), with and with-
out ceftazidime (1 μg/mL) or cefotaxime 
(1 μg/mL) and incubated for 24 h at 37°C. Up to 
3 colonies with typical Enterobacteriaceae mor-
phology from each sample were selected and 
subcultured onto MacConkey agar for 24 hours 
at 37°C. The identified isolates were confirmed 
using API ID 32 E (bioMérieux) and by conven-
tional biochemical methods. 
Antibiotic susceptibility was determined by the 
broth microdilution method on Mueller–Hin-
ton broth (bioMerieux, Florence, Italy), ac-
cording to the Clinical Laboratory Standards 
Institute (CLSI) guidelines 2012. The following 
antimicrobials were tested: ampicillin (AM), 
amoxicillin/clavulanic acid (AMC), cephalothin 
(CF), cefuroxime (CXM), cefpodoxime (CPD), 
cefotaxime (CTX), ceftazidime (CAZ), cefepime 
(FEP), cefoxitin (FOX), imipenem (IMP); (all 
the antimicrobials were purchased from Sig-
ma Aldrich, Milan, Italy). The European Com-
mittee on Antimicrobial Susceptibility Testing 
guidelines for the susceptibility categorization 
(EUCAST, 2013) were used and E. coli ATCC 
25922 was employed as quality control strain. 
ESBL-producing isolates were screened by the 
phenotypic confirmatory test, using both ce-
fotaxime and ceftazidime alone and in combi-
nation with clavulanic acid, according to CLSI 
recommendations.
Bacterial isolates confirmed for their capacity 
to produce ESBLs were further analysed by 
PCR. DNA was extracted using a standard heat 
lysis protocol (Pèrez-Pèrez et al., 2002). There-
after, specific primers were used to search for 
blaTEM, blaSHV e blaCTX-M (Kim et al., 2009).
PCR-positive amplicons were purified with the 
QIAquick PCR Purification Kit (Qiagen, Milan, 
Italy) and directly sequenced using amplifica-
tion primers on the 3130 Genetic Analyzer (Ap-
plied Biosystems). Purification and sequencing 
were carried out by Genex CZ, s.r.o. Sequence 
alignment and the analysis were performed on-
line using the BLAST program of the National 
Center for Biotechnology Information (www.
ncbi.nlm.nih.gov).
Conjugal transfer of resistance determinants 
was performed in liquid medium using the 
E. coli J53-2 (met-, pro-, rifR) as recipient. 
Transconjugants were selected on MacConkey 
agar containing cefotaxime (2 mg/L) plus rifam-
picin (100 mg/L). For plasmid analysis, plasmid 
DNA was obtained from the transconjugants 
using the QIAGEN plasmid Midi kit, (Qiagen, 
Milan, Italy) following the manufacturer’s in-
structions. Transconjugants harboring a single 
plasmid, originated from the ESBL-producing 
isolates, were subsequently selected and inves-
tigated. E. coli V517 (53.7, 5.6, 5.1, 3.9, 3.0, 2.7, 
et 2.1 kb) was used as the standard marker for 
plasmid size analysis (Macrina et al., 1978) and 
the presence of beta-lactamase genes was con-
firmed by PCR, as described above. 
A total of 56 Enterobacteriaceae strains were 
isolated and identified by means of their bio-
chemical properties and confirmed with API 
ID 32 E. Among the identified strains, the iso-
lated species were: Escherichia coli (n=34), 
Pseudomonas aeruginosa (n=11), Pseudomonas 
fluorescens (n=1), Klebsiella ozaenae (n=7), 
Acinetobacter lwoffi (n=2) and Proteus mirabilis 
(n=1). Broad-spectrum cephalosporin-resistant 
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enzymes were found in 25 isolates (44%) using 
the double-disk synergy test and the strains con-
taining ESBL were detected in 20 (36%) of them, 
of which 15 E. coli and 5 K. ozaenae (Table 1).
The PCR products from the ESBL-producing E. 
coli strains were directly sequenced, analyzed, 
and of the 15 E. coli, 4 isolates were identified 
as blaCTX-M-1 and 2 isolates as blaCTXM-15, in 2 iso-
lates the blaCTX-M-1 gene was found in combina-
tion with the blaTEM-201 gene, in other 2 isolates 
the blaTEM-1 gene was found in combination with 
the blaCTX-M- 1 and finally in 5 isolates the blaTEM-52 
gene was found.
In the 5 K. ozaenae strains, the blaTEM-1 gene, 
was found in 3 isolates in combination with the 
blaCTX-M-1, and in combination with the blaCTX-M-15 
in 1 isolate. In addition, the blaTEM-24 gene was 
found, in combination with the blaCTX-M-1 in 1 
isolate only.
Seven out of 15 E. coli and all the 5 K. ozaenae 
isolates were able to transfer the ESBL phe-
notype to a recipient. The presence of the re-
spective β-lactamase genes was confirmed in all 
transconjugants by PCR analysis, with primers 
encoding CTX-M or TEM-type ESBLs. The con-
jugation assays yielded positive results, thus de-
noting a plasmidic localization of the genes. 
Recently, there has been an increase in stud-
ies in several countries describing the preva-
lence and characteristics of ESBL-producing 
Enterobacteriaceae in hospitalized companion 
animals (Sidjabat et al., 2007), in cattle (Bar-
donˇ et al., 2013, Pitout et al., 2012, Reist et al., 
2013, Prescott et al., 2008) and pigs and chicken 
(Guardabassi et al., 2004, Hasman et al., 2005, 
Hansen et al., 2013).
The results shown in the present investigation 
emphasize the role of livestock animals in the 
spread of ESBL-producing Enterobacteriaceae, 
and the risk that these microorganisms can 
reach humans through the food chain. In fact, 
36% (20/56) of the analyzed bacterial strains 
TABLE 1 - Identification, minimum inhibitory concentrations (MICs) and further characterization  
of the 20 ESBL producers isolated from 100 rectal swabs of livestock animals. 
Sample 
number
Species Origin Antimicrobial agent/MIC value (mg/l) ESBL 
test 
result
Plasmide β-lactamase 
genes detected
AM AMC CAZ CTX FEP CF CXM CPD FOX IMP
13 E. coli Pig >32 >32 1 4 2 8 >32 2 4 <0.25 + blaTEM-52
39 E. coli Pig >32 >32 2 >64 <4 4 >32 4 32 <0.25 + blaTEM-52
40 E. coli Pig >32 >32 2 >64 4 8 >32 14 64 <0.25 + blaTEM-52
41 E. coli Pig >32 >32 4 >64 2 8 >32 8 8 <0.25 + blaCTX-M-1
42 E. coli Pig >32 >32 4 >64 4 4 >32 >16 8 <0.25 + blaTEM-201 + blaCTX-M-1
43 E. coli Pig >32 >32 4 >64 4 8 >32 >16 8 <0.25 + blaTEM-1 + blaCTX-M-1
44 E. coli Pig >32 >32 4 >64 8 >16 >32 >16 32 <0.25 + blaCTX-M-15
45 E. coli Pig >32 >32 4 >16 >16 4 >32 >16 8 0.5 + blaCTX-M-1
46 E. coli Pig >32 16 4 >16 >16 8 16 8 8 0.5 + blaCTX-M-1
47 E. coli Pig >32 >32 2 >64 4 8 >32 8 8 <0.25 + blaTEM-52
48 E. coli Pig >32 >32 2 >64 4 8 >32 8 4 <0.25 + blaTEM-52
49 E. coli Pig >32 >32 4 >64 2 8 >32 8 4 <0.25 + blaCTX-M-1
51 E. coli Pig >32 >32 4 >64 16 8 >32 4 4 <0.25 + blaTEM-201 + blaCTX-M-1
54 E. coli Pig >32 >32 4 >64 2 8 >32 4 8 <0.25 + blaTEM-1 + blaCTX-M-1
56 E. coli Pig >32 >32 4 >64 2 4 >32 4 32 <0.25 + blaCTX-M-15
6 K. ozaenae Cattle >32 >32 <1 8 2 8 16 4 8 <0.25 + blaTEM-1 + blaCTX-M-1
7 K. ozaenae Cattle >32 >32 <1 8 2 4 16 4 8 <0.25 + blaTEM-1 + blaCTX-M-1
8 K. ozaenae Cattle >32 >32 2 16 2 8 >32 4 8 <0.25 + blaTEM-1 + blaCTX-M-15
9 K. ozaenae Cattle >32 >32 2 8 2 8 >32 4 128 <0.25 + blaTEM-1 + blaCTX-M-1
12 K. ozaenae Cattle >32 >32 2 8 2 8 >32 2 8 <0.25 + blaTEM-24 + blaCTX-M-1
ESBL, extended-spectrum β-lactamase; MIC, minimum inhibitory concentration; AM, ampicillin; AMC, amoxicillin/clavulanic acid; CTX, 
cefotaxime; CAZ, ceftazidime; FEP, cefepime; cephalothin CF; cefuroxime CXM; cefpodoxime CPD; FOX, cefoxitin; IMP, imipenem.
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were positive for ESBL production; of these 
75% were E. coli and 25% were K. ozaenae. In 
accordance with previous studies (Blanc et al., 
2006, Smet et al., 2008, Endimiani et al., 2012, 
Genser et al., 2012, Rodrigues et al., 2013), this 
molecular analysis demonstrates that the most 
dominant types of enzymes were CTX-M-1 and 
TEM-52. While CTX-M-14 is among the most 
prevalent beta lactamase types in companion 
animals and poultry in Asia (30-33%), and to a 
lesser extent in cattle and pigs (14%), it is less 
prevalent in livestock (4-7%) in Europe, and 
is even absent in companion animals (Ewers 
et al., 2012). All of the TEM enzymes, co-ex-
pressed with CTX-M ESBLs, were broad-spec-
trum β-lactamases whereas most TEM-1 en-
zymes did not match with the ESBL phenotype. 
In contrast, 3 strains expressing TEM enzymes 
featured TEM-ESBLs, TEM-24 and TEM-201 
(Table 1). In some countries, TEM-ESBLs are 
much more frequently found in animals, es-
pecially in chickens (Costa et al., 2009, Smet 
et al., 2011, Dierikx et al., 2012). Since the role 
of farm animals in the dissemination of micro-
organisms endowed with antibiotic resistance 
characteristics is now widely recognized, our 
work represents a contribution to the identifi-
cation, characterization and distribution of ES-
BL-producing Enterobacteriaceae in the field of 
veterinary microbiology. Another major issue is 
the difficulty in monitoring the use of antibi-
otics in animals and their off-label implemen-
tation for non-authorized indications. Lastly, 
mobile drug resistance genes capable of cross-
ing bacterial species are likely to accelerate dis-
semination of drug resistance from animals to 
humans through the consumption of chicken, 
beef and pork. 
Notwithstanding the consistency of other Eu-
ropean studies, very little can be found in the 
literature showing a countrywide prevalence in 
Italy.
Additional nationwide surveys are warranted 
to identify the possible spread of ESBL-produc-
ing Enterobacteriaceae, their dynamic of trans-
mission and the risk factors. It is important 
to monitor the spread of expanded-spectrum 
cephalosporin resistance, and further genetic 
studies are necessary for the control of drug-re-
sistant bacteria in animals, humans and the en-
vironment.
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